Each licensee or registrant shall ensure that individuals who are required to monitor occupational doses in accordance with 10 CFR 20.1502 wear individual monitoring devices as follows:

1. An individual monitoring device used for monitoring the dose to the whole body shall be worn at the unshielded location of the whole body likely to receive the highest exposure. When a protective apron is worn, the location of the individual monitoring device is typically at the neck (collar);

2. An individual monitoring device used for monitoring the dose to an embryo or fetus of a declared pregnant woman, pursuant to 10 CFR 20.1208, shall be located at the waist under any protective apron being worn by the woman;

3. An individual monitoring device used for monitoring the lens dose equivalent, to demonstrate compliance with subparagraph a of 10 CFR 20.1201, shall be located at the neck (collar), outside any protective apron being worn by the monitored individual, or at an unshielded location closer to the eye; and

4. An individual monitoring device used for monitoring the dose to the extremities, to demonstrate compliance with subparagraph a of 10 CFR 20.1201, shall be worn on the extremity likely to receive the highest exposure. Each individual monitoring device shall be oriented to measure the highest dose to the extremity being monitored.

History: Effective January 1, 2019.

General Authority: NDCC 23.1-03-04; S.L. 2017, ch. 199, § 1

Law Implemented: NDCC 23.1-03-03, 23.1-03-04; S.L. 2017, ch. 199, § 18